Literature DB >> 1134405

The ethics and morality of clinical trials in man.

D J Whalan.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 1134405

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  8 in total

Review 1.  The ethics of placebos in AIDS drug trials.

Authors:  J D Porter; B D Forrest; A R Kennedy
Journal:  HEC Forum       Date:  1992

2.  Letter from South Australia: Afflictions and admonitions.

Authors:  P Rhodes
Journal:  Br Med J       Date:  1975-11-08

3.  Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Authors:  Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

4.  The Association between Sleep Duration and Non-Alcoholic Fatty Liver Disease among Japanese Men and Women.

Authors:  Hiromichi Imaizumi; Atsushi Takahashi; Nobuo Tanji; Kazumichi Abe; Yuji Sato; Yukio Anzai; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Obes Facts       Date:  2015-07-01       Impact factor: 3.942

5.  Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease.

Authors:  Shoko Kuriyama; Yoshiyuki Miwa; Hideki Fukushima; Hironori Nakamura; Katsuhisa Toda; Makoto Shiraki; Masahito Nagaki; Mayumi Yamamoto; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114

6.  Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.

Authors:  Motoi Hashiba; Masafumi Ono; Hideyuki Hyogo; Yukio Ikeda; Kosei Masuda; Reiko Yoshioka; Yoichi Ishikawa; Yuri Nagata; Kensuke Munekage; Tsunehiro Ochi; Akira Hirose; Yasuko Nozaki-Fujimura; Shuhei Noguchi; Nobuto Okamoto; Kazuaki Chayama; Narufumi Suganuma; Toshiji Saibara
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

7.  Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS.

Authors:  Tsunehiro Ochi; Takumi Kawaguchi; Takashi Nakahara; Masafumi Ono; Shuhei Noguchi; Yuichi Koshiyama; Kensuke Munekage; Eisuke Murakami; Akira Hiramatsu; Mitsunari Ogasawara; Akira Hirose; Hiroshi Mizuta; Kosei Masuda; Nobuto Okamoto; Narufumi Suganuma; Kazuaki Chayama; Masahiro Yamaguchi; Takuji Torimura; Toshiji Saibara
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

8.  Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.

Authors:  Yusuke Oki; Masafumi Ono; Hideyuki Hyogo; Tsunehiro Ochi; Kensuke Munekage; Yasuko Nozaki; Akira Hirose; Kosei Masuda; Hiroshi Mizuta; Nobuto Okamoto; Toshiji Saibara
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-07       Impact factor: 2.566
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.